Skip to main content

MAXIMUS, INC.

corporate_fare Company Profile

MAXIMUS, INC.

MMS·NYSE·Trade & Services·CIK 0001032220

General Maximus, a Virginia corporation established in 1975, provides tech-enabled services to government agencies. The company helps improve public service delivery for over 100 million American citizens, as well as citizens in the U.K., Canada, and the Middle East. General Maximus primarily serves U.S. federal and state customers by designing, developing, and delivering programs that enhance government effectiveness. The company translates public policy into operating models to achieve outcomes for governments at scale. General Maximus's services include operating large health insurance eligibility and enrollment programs, clinical services such as assessments, appeals, and independent medical reviews, and technology services. These services benefit from increasing industry demand, constrained government budgets, and a focus on technology as governments prioritize modernization. The company also provides rapid response services, including digitally enabled contact center support for natural disasters and swift establishment of public health and safety initiatives. A key strategic priority is Tech-Enabled Customer Service. General Maximus uses business intelligence, predictive analytics, and emerging technologies to support government agency missions. The company aims to detect and resolve barriers to reach target populations, striving for higher satisfaction, performance accuracy, and accountability for government customers. General Maximus implements complex public policy with efficient technology-based solutions. Its Total Experience Management platform is Federal Risk and Authorization Management Program (FedRAMP) secure, modular, and scalable, helping federal agencies deliver citizen-centric services.

MAXIMUS, INC. (NYSE:MMS) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 11 items for MMS at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-06, rated 8/10. Across its 11 most recent items scored 7 or higher, the top rating is 9/10, with 7 rated 8 or above. Recent SEC coverage for MMS spans 10-Q, 8-K, DEF 14A.

Recent high-impact activity:

  • Maximus Q3 Revenue Misses, Guides Lower on Federal Contract Headwind
  • Maximus Q3 Revenue Misses, But EPS Beats; Guidance Cut on Federal Contract Modification
  • Maximus Q3 Revenue Misses, Guidance Cut on Contract Change
  • Maximus Secures $325M Term Loan to Fund Share Buybacks, Repay Debt
  • MAXIMUS Secures $325M Term Loan, Partially Funding Share Repurchase Program

Financial Snapshot

Fiscal year ended September 30, 2025
Revenue
$5.43B
Net Income
$319.03M
Diluted EPS
$5.51
Op. Cash Flow
$429.37M
Free Cash Flow
$366.16M
Gross Profit
$1.33B
Operating Income
$528.29M
Cash & Equivalents
$222.35M
Total Debt
$1.33B
Debt / Equity
0.80×
Net Margin
5.9%
Shares Outstanding
54.8M sh
Source: 10-K · filed 2025-11-20 · accession 0001032220-25-000053

Short Interest & Short Volume

5.76 days to cover

FINRA reported short interest of 3,304,066 shares in MMS as of the September 15, 2026 settlement, a 2.8% increase from the prior period — about 5.8 days to cover at its recent average daily volume. On October 2, 2026, 56.6% of MMS volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)3,304,066 shares as of September 15, 2026
Change vs prior period▲ 2.8%
Days to cover5.76 at avg daily volume of 573,374
Daily short volume (FINRA facilities)56.6% of 237,917 shares on October 2, 2026
5-day average short volume40.3%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with M →
$52.65
52-week range · as of 2026-08-06 $52.65 – $100
Market cap
$2.76B
Volume
610.1K (0.9× avg)
3-mo avg 647.9K
Live data · 2026-10-04 06:12 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed MMS - Latest Insights

MMS
Aug 06, 2026, 10:47 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $57.76
Real-time Price: $52.65 info
Change: -$5.11 (-9%) info
Market Cap: $2.757B info
MMS
Aug 06, 2026, 8:25 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $58.80
Real-time Price: $52.65 info
Change: -$6.15 (-10%) info
Market Cap: $2.757B info
MMS
Aug 06, 2026, 6:46 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $62.04
Real-time Price: $52.65 info
Change: -$9.39 (-15%) info
Market Cap: $2.757B info
MMS
May 28, 2026, 4:23 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $62.88
Real-time Price: $52.65 info
Change: -$10.23 (-16%) info
Market Cap: $2.757B info
MMS
May 28, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $62.88
Real-time Price: $52.65 info
Change: -$10.23 (-16%) info
Market Cap: $2.757B info
MMS
May 07, 2026, 11:35 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $67.25
Real-time Price: $52.65 info
Change: -$14.60 (-22%) info
Market Cap: $2.757B info
MMS
May 07, 2026, 7:28 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $64.30
Real-time Price: $52.65 info
Change: -$11.65 (-18%) info
Market Cap: $2.757B info
MMS
May 07, 2026, 6:44 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $64.30
Real-time Price: $52.65 info
Change: -$11.65 (-18%) info
Market Cap: $2.757B info
MMS
Feb 05, 2026, 11:04 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $80.25
Real-time Price: $52.65 info
Change: -$27.60 (-34%) info
Market Cap: $2.757B info
MMS
Feb 05, 2026, 7:17 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $94.35
Real-time Price: $52.65 info
Change: -$41.70 (-44%) info
Market Cap: $2.757B info
MMS
Jan 22, 2026, 4:32 PM EST
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $98.93
Real-time Price: $52.65 info
Change: -$46.28 (-47%) info
Market Cap: $2.757B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets